SUNNYVALE, Calif.--(BUSINESS WIRE)--May 4, 2006--Adeza (NASDAQ:ADZA - News) today announced the submission of a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Gestiva(TM), the company’s drug candidate to prevent preterm birth in women with a history of preterm delivery.
